Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3057% below fair value
$58.11−1.30 (-2.19%)
Close on Nov 18, 2026Market cap $1.68BP/E 12.6Yield –
Inspire Medical Systems revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Inspire Medical Systems's revenue for the twelve months ending Jun 30, 2026 was $898.74M, up 4.3% year over year. For fiscal 2025 it was $911.98M, up 13.6% from the year before. The highest annual figure on record is $911.98M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $911.98M | +13.6% |
| FY2024 | Dec 31, 2024 | $802.80M | +28.5% |
| FY2023 | Dec 31, 2023 | $624.80M | +53.2% |
| FY2022 | Dec 31, 2022 | $407.86M | +74.7% |
| FY2021 | Dec 31, 2021 | $233.39M | +102.3% |
| FY2020 | Dec 31, 2020 | $115.38M | +40.6% |
| FY2019 | Dec 31, 2019 | $82.05M | +62.2% |
| FY2018 | Dec 31, 2018 | $50.59M | +77.1% |
| FY2017 | Dec 31, 2017 | $28.57M | +73.9% |
| FY2016 | Dec 31, 2016 | $16.43M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $200.58M | -7.6% |
| Q1 FY2026 | Mar 31, 2026 | $204.58M | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | $269.08M | +12.2% |
| Q3 FY2025 | Sep 30, 2025 | $224.50M | +10.5% |
| Q2 FY2025 | Jun 30, 2025 | $217.09M | +10.8% |
| Q1 FY2025 | Mar 31, 2025 | $201.32M | +22.7% |
| Q4 FY2024 | Dec 31, 2024 | $239.72M | +24.5% |
| Q3 FY2024 | Sep 30, 2024 | $203.19M | +32.5% |
| Q2 FY2024 | Jun 30, 2024 | $195.89M | +29.6% |
| Q1 FY2024 | Mar 31, 2024 | $164.01M | +28.2% |
| Q4 FY2023 | Dec 31, 2023 | $192.51M | +39.6% |
| Q3 FY2023 | Sep 30, 2023 | $153.30M | +40.4% |
| Q2 FY2023 | Jun 30, 2023 | $151.09M | +65.3% |
| Q1 FY2023 | Mar 31, 2023 | $127.90M | +84.3% |
| Q4 FY2022 | Dec 31, 2022 | $137.90M | +75.9% |
| Q3 FY2022 | Sep 30, 2022 | $109.19M | +77.0% |
| Q2 FY2022 | Jun 30, 2022 | $91.39M | +72.6% |
| Q1 FY2022 | Mar 31, 2022 | $69.38M | +71.9% |
| Q4 FY2021 | Dec 31, 2021 | $78.40M | +70.4% |
| Q3 FY2021 | Sep 30, 2021 | $61.69M | +72.1% |
| Q2 FY2021 | Jun 30, 2021 | $52.96M | +334.7% |
| Q1 FY2021 | Mar 31, 2021 | $40.35M | +89.0% |
| Q4 FY2020 | Dec 31, 2020 | $46.01M | +71.0% |
| Q3 FY2020 | Sep 30, 2020 | $35.84M | +71.8% |
| Q2 FY2020 | Jun 30, 2020 | $12.18M | -32.4% |
| Q1 FY2020 | Mar 31, 2020 | $21.35M | +31.4% |
| Q4 FY2019 | Dec 31, 2019 | $26.91M | +62.5% |
| Q3 FY2019 | Sep 30, 2019 | $20.86M | +59.8% |
| Q2 FY2019 | Jun 30, 2019 | $18.03M | +64.9% |
| Q1 FY2019 | Mar 31, 2019 | $16.25M | +61.8% |
| Q4 FY2018 | Dec 31, 2018 | $16.56M | +66.3% |
| Q3 FY2018 | Sep 30, 2018 | $13.05M | +79.5% |
| Q2 FY2018 | Jun 30, 2018 | $10.94M | +81.0% |
| Q1 FY2018 | Mar 31, 2018 | $10.04M | +89.6% |
| Q4 FY2017 | Dec 31, 2017 | $9.96M | – |
| Q3 FY2017 | Sep 30, 2017 | $7.27M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.04M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.30M | – |
See a number that looks wrong?